Randomised controlled study comparing oral and vaginal misoprostol for cervical priming prior to surgical termination of pregnancy

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 110, Issue 12, 2003, Pages 1057-1061

  Ashok, Premila W ^a   Hamoda, Haitham ^a   Nathani, Fatima ^b   Flett, Gillian M M ^b   Templeton, Allan ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b NHS GRAMPIAN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MISOPROSTOL;

ADULT; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FATIGUE; FEMALE; HUMAN; INTRAOPERATIVE PERIOD; NAUSEA; NURSING STAFF; PREGNANCY; PREGNANCY TERMINATION; PREOPERATIVE PERIOD; PRIMIGRAVIDA; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SURGICAL TECHNIQUE; TEACHING HOSPITAL; UTERINE CERVIX DILATATION; VACUUM ASPIRATION;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTION, INDUCED; ADMINISTRATION, INTRAVAGINAL; ADMINISTRATION, ORAL; ADULT; ATTITUDE OF HEALTH PERSONNEL; CERVICAL RIPENING; FEMALE; HUMANS; MISOPROSTOL; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREOPERATIVE CARE;

EID: 0344234421     PISSN: 14700328     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2003.03115.x     Document Type: Article

References (25)

1. Grimes D.A., Schulz K.F., Cates W.J. Jr. Prevention of uterine perforation during curettage abortion. JAMA. 251(16):1984;2108-2111.
2. Schulz K.F., Grimes D.A., Cates W. Jr. Measures to prevent cervical injury during suction curettage abortion. Lancet. 1(8335):1983;1182-1185.
3. The Care of Women Requesting Induced Abortion. 2000;RCOG Press, London.
4. Ashok P.W., Flett G.M., Templeton A. Mifepristone versus vaginally administered misoprostol for cervical priming before first-trimester termination of pregnancy: a randomized, controlled study. Am J Obstet Gynecol. 183(4):2000;998-1002.
5. El Refaey H., Calder L., Wheatley D.N., Templeton A. Cervical priming with prostaglandin E1 analogues, misoprostol and gemeprost. Lancet. 343(8907):1994;1207-1209.
6. Lawrie A., Penney G., Templeton A. A randomised comparison of oral and vaginal misoprostol for cervical priming before suction termination of pregnancy. Br J Obstet Gynaecol. 103(11):1996;1117-1119.
7. Ngai S.W., Yeung K.C., Lao T., Ho P.C. Oral misoprostol versus vaginal gemeprost for cervical dilatation prior to vacuum aspiration in women in the sixth to twelfth week of gestation. Contraception. 51(6):1995;347-350.
8. Carbonell J.L., Velazco A., Rodriguez Yet al. Oral versus vaginal misoprostol for cervical priming in first-trimester abortion: a randomized trial. Eur J Contracept Reprod Health Care. 6(3):2001;134-140.
9. Macisaac L., Grossman D., Balistreri E., Darney P. A randomized controlled trial of laminaria, oral misoprostol, and vaginal misoprostol before abortion. Obstet Gynecol. 93(5 Pt 1):1999;t-70.
10. Singh K., Fong Y.F., Prasad R.N., Dong F. Vaginal misoprostol for pre-abortion cervical priming: is there an optimal evacuation time interval? Br J Obstet Gynaecol. 106(3):1999;266-269.
11. Fisher J., Anthony G.S., McManus T.J., Coutts J.R., Calder A.A. Use of a force measuring instrument during cervical dilatation. J Med Eng Technol. 5(4):1981;194-195.
12. Henshaw R.C., Templeton A.A. Pre-operative cervical preparation before first trimester vacuum aspiration: a randomized controlled comparison between gemeprost and mifepristone (RU 486). Br J Obstet Gynaecol. 98(10):1991;1025- 1030.
13. Gore S.M., Altman D.G. Statistics in Practice. 1992;British Medical Association, London.
14. SPSS Reference Guide, Version 11. Chicago: SPSS, 2001.
15. Fong Y.F., Singh K., Prasad R.N. A comparative study using two dose regimens (200 microg or 400 microg) of vaginal misoprostol for pre-operative cervical dilatation in first trimester nulliparae. Br J Obstet Gynaecol. 105(4):1998;413-417.
16. Ho P.C., Ngai S.W., Liu K.L., Wong G.C., Lee S.W. Vaginal misoprostol compared with oral misoprostol in termination of second-trimester pregnancy. Obstet Gynecol. 90(5):1997;735-738.
17. Carbonell J.L., Varela L., Velazco A., Fernandez C. The use of misoprostol for termination of early pregnancy. Contraception. 55(3):1997;165-168.
18. Creinin M.D., Carbonell J.L., Schwartz J.L., Varela L., Tanda R. A randomized trial of the effect of moistening misoprostol before vaginal administration when used with methotrexate for abortion. Contraception. 59(1):1999;11-16.
19. Ngai S.W., Tang O.S., Lao T., Ho P.C., Ma H.K. Oral misoprostol versus placebo for cervical dilatation before vacuum aspiration in first trimester pregnancy. Hum Reprod. 10(5):1995;1220-1222.
20. Ngai S.W., Yeung K.C., Lao T., Ho P.C. Oral misoprostol versus mifepristone for cervical dilatation before vacuum aspiration in first trimester nulliparous pregnancy: a double blind prospective randomised study. Br J Obstet Gynaecol. 103(11):1996;1120-1123.
21. Platz-Christensen J.J., Nielsen S., Hamberger L. Is misoprostol the drug of choice for induced cervical ripening in early pregnancy termination? Acta Obstet Gynecol Scand. 74(10):1995;809-812.
22. Carbonne B., Brennand J.E., Maria B., Cabrol D., Calder A.A. Effects of gemeprost and mifepristone on the mechanical properties of the cervix prior to first trimester termination of pregnancy. Br J Obstet Gynaecol. 102(7):1995;553-558.
23. Tang O.S., Ho P.C. Pilot study on the use of sublingual misoprostol for medical abortion. Contraception. 64(5):2001;315-317.
24. Tang O.S., Miao B.Y., Lee S.W.H., Ho P.C. Pilot study on the use of repeated doses of sublingual misoprostol in termination of pregnancy up to 12 weeks gestation: efficacy and acceptability. Hum Reprod. 17(3):2002;654-658.
25. Tang O.S., Schweer H., Seyberth H.W., Lee S.W.H., Ho P.C. Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod. 17(2):2002;332-336.